Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis

Fig. 3

The effect of SGLT2 inhibitors vs placebo on the risk of outcomes for the patients with HFmrEF or HFpEF. Forest plot for the SGLT2 inhibitors versus placebo in patients with heart failure: A HFmrEF; B HFpEF. HFmrEF = heart failure with preserved ejection fraction; HFpEF = heart failure with mildly reduced ejection fraction

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us